Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma.
about
Long-term outcomes of helper peptide vaccination for metastatic melanoma.Melanoma vaccines: mixed past, promising future.PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells.Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers.
P2860
Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@en
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@nl
type
label
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@en
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@nl
prefLabel
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@en
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@nl
P2093
P2860
P356
P1476
Follow-up analysis of a random ...... ic clinical trial on melanoma.
@en
P2093
Andrea L George
Jan Geliebter
Marc Wallack
Raj K Tiwari
Robert Suriano
Shilpi Rajoria
P2860
P304
P356
10.3892/MCO.2013.97
P577
2013-03-20T00:00:00Z